Aurobindo Pharma commissions four plants in Andhra Pradesh including Pen-G facility


Hyderabad: Aurobindo Pharma Said on Monday that it has launched four state-of-the-art services manufacturing facilities For Penicillin-G, 6-Amino Penicillinic Acid (6-APA), injectable products and Granulation, through its wholly owned subsidiaries. penicillin g The (Pen-G) facility, located in an SEZ in Kakinada, Andhra Pradesh, has a production capacity of 15,000 tonnes per annum and 1.8 lakh tonnes of gulakose, while the 6-Amino Penicillin Acid plant has a capacity to produce 3,600 tonnes per annum. the drugmaker said in a press release.
The Rs 2,400-crore Pen-G plant is expected to begin trial production in April and commercial production in a few months and ramp up production during the second quarter of the current fiscal, according to a senior city-based official. The drug manufacturer had said earlier.
The plant was sanctioned under the Production Linked Incentive (PLI) Scheme to promote domestic manufacturing of Critical Starting Materials (KSMs)/Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the country.
Aurobindo said the injectable plant has the capacity to produce 285 million vials/ampoules annually and the granular products plant will produce 13,200 tonnes annually.

Related Post

Leave a Reply

Your email address will not be published. Required fields are marked *